Bristol Myers Squibb’s Post

Today, we announced topline results from two pivotal Phase 3 trials for an investigational medicine in adults with #PsoriaticArthritis. Our research underscores our commitment to following the science to help more patients with immune-mediated rheumatic diseases potentially achieve their treatment goals. Learn more about the topline results: https://bit.ly/4iHxO1o

  • No alternative text description for this image

It’s exciting to see science leading the way to better outcomes for patients with immune-mediated diseases. We look forward to following these developments and their potential impact on patient care. #PsoriaticArthritis #MedicalResearch #ImmuneDiseases #ClinicalTrials #InnovationInHealthcare #PatientCare #OrientTelecoms #FollowingTheScience

Like
Reply
Timothy Toups

Regional Sales Manager

7h

What happened to Zeposia ?

Like
Reply
Surabhi Panda

Medical Student at Rowan SOM | Computer Engineering at RU | Former BA at BMS R&D Portfolio Operations

4h

This is exciting!!

Like
Reply
Francesca Hamilton

Associate Director - QC labs at Bristol-Myers Squibb

12h

Amazing strides

Like
Reply
Sukumar C

Regional Sales Manager at Dr Reddy's Laboratories

1d

I am looking a job as Regional Sales Manager in Coimbatore HQ Tamilnadu India. Pls let me know

Like
Reply

Congratulations to the amazing Sotyktu team!

Like
Reply
Niko Golod

I am a bright, biotech investments-loving guy.

1d

God bless you and KARxt that's gonna be a revolution!

Like
Reply
Mohan Pandey

Pharmaceutical Leader | Reimagining R&D Management | Building Enduring Value | Syngene, SARC | ex-BMS, BBRC, Dr Reddy's

1d

Remarkable results. Happy memories here. Great job Roland and team!

Like
Reply
Joe DiMatteo

Associate Director Regional Marketing

1d

Congrats!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics